-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Shares
-
Latest Disclosed Ownership
-
509K shares
-
Security Ownership
-
19.9%
Hanmi Pharmaceutical Co., Ltd. ownership in Aptose Biosciences Inc. Common Shares
2025-03-20 - Hanmi Pharmaceutical Co., Ltd. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 509K shares of Aptose Biosciences Inc. Common Shares.
This represents 19.9% percent ownership of the company.